Hanmi Pharmaceutical
South Korea-based Hanmi Pharmaceutical is seeking to be a world-leading pharma company focused on developing new biologics, new chemical entities, and innovative new drugs.
The company, established in 1973, has a motto ‘to develop better drugs for precious lives’, and aims to advance to the global market as a representative of the Korean pharmaceutical industry by focusing on research and development.
It is expected to become the first Korean company to develop a new global drug as clinical trials are conducted in the USA and Europe to develop diabetes and anti-cancer drugs.
Latest Hanmi Pharmaceutical News & Features
4 January 2023
28 November 2022
23 September 2022
Today's issue
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze